menu
    • menu
    [{"orgOrder":0,"company":"Prolacta Bioscience","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Bifidobacterium Infantis","moa":"Bacteria microbiome","graph1":"Oncology","graph2":"Phase II","graph3":"Prolacta Bioscience","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Prolacta Bioscience \/ Inapplicable","highestDevelopmentStatusID":"8","companyTruncated":"Prolacta Bioscience \/ Inapplicable"},{"orgOrder":0,"company":"Helmholtz Zentrum M\u00fcnchen","sponsor":"Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal ","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Bifidobacterium Infantis","moa":"Bacteria microbiome","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Helmholtz Zentrum M\u00fcnchen","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Helmholtz Zentrum M\u00fcnchen \/ Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal ","highestDevelopmentStatusID":"1","companyTruncated":"Helmholtz Zentrum M\u00fcnchen \/ Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal "}]

    Find Clinical Drug Pipeline Developments & Deals for Bifidobacterium Infantis

    Menu

    Bifidobacterium Infantis

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Prolacta Bioscience

                            Country arrow
                            Pharmaconex
                            Not Confirmed

                            Prolacta Bioscience

                            Country arrow
                            Pharmaconex
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bifidobacterium Infantis

                            Therapeutic Area : Oncology

                            Study Phase : Phase II

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving...

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            October 26, 2023

                            Lead Product(s) : Bifidobacterium Infantis

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase II

                            Sponsor : Inapplicable

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Helmholtz Zentrum München

                            Germany arrow
                            Pharmaconex
                            Not Confirmed

                            Helmholtz Zentrum München

                            Germany arrow
                            Pharmaconex
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bifidobacterium Infantis

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            February 24, 2021

                            Lead Product(s) : Bifidobacterium Infantis

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : Technical University of Munich | Kinderkrankenhaus auf der Bult | University Hospital Carl Gustav Carus | Skane University Hospital | Universitaire Ziekenhuizen KU Leuven | Medical University of Warsaw | Cambridge Biomedical Campus, Cambridge, UK | Royal

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            American Academy of Family Physicians

                            Country arrow
                            Pharmaconex
                            Not Confirmed

                            American Academy of Family Physicians

                            Country arrow
                            Pharmaconex
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Bifidobacterium Infantis

                            Therapeutic Area : Gastroenterology

                            Study Phase : Phase IV

                            Sponsor : Genova Diagnostics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Irritable Bowel Syndrome Evaluation and Treatment in Primary Care

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            July 16, 2012

                            Lead Product(s) : Bifidobacterium Infantis

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Phase IV

                            Sponsor : Genova Diagnostics

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth